Lilly agrees to buy 381,354 Richter treasury shares for about $15 million
LLY•Eli Lilly will acquire 381,354 ordinary shares from Gedeon Richter’s treasury for about $15 million, or approximately $39.33 per share. The investment accompanies an exclusive worldwide license to develop medicines combining Richter’s Estetrol with Lilly compounds; closing requires antitrust clearance and other customary conditions.
1. Share purchase
Eli Lilly will acquire 381,354 ordinary shares from Gedeon Richter’s treasury for approximately $15 million. The approximately $39.33-per-share price reflects the Budapest Stock Exchange volume-weighted average over the 30 trading days before signing.
2. Worldwide license
The investment accompanies an exclusive worldwide license to develop medicines combining Richter’s Estetrol with Lilly compounds for women’s health and cardiometabolic diseases. Closing is subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act and other customary conditions.
